Oligossacarídeos

The structure of GD2-oligosaccharide-sp-biotin (sodium salt) comprises (GalNAcβ1,4Galβ1,4Glc) with two sialic acids linked (β-2,3/β-2,8) to the central galactose residue and biotin attached to position 1 of the reducing glucose moiety. GD2 ganglioside is expressed at a low concentration in the central nervous system, nerves, skin melanocytes and stem cells in healthy adults. On the other hand, GD2 ganglioside is overexpressed in a number of tumors, including: neuroblastoma, melanoma, small cell lung carcinoma and brain tumors. Recently, it has been found in low concentrations on breast cancer stem cells (CSC) that possess: self-renewal properties (division without disrupting the undifferentiated state) and tumor-initiating capabilities. It has been suggested that GD2 ganglioside may be developed as an effective target antigen for CSC immunotherapy.

Glycyl-monosialyllacto-N-neohexose I is a monosaccharide that is used as a building block in the synthesis of complex carbohydrates. It is custom synthesized and purified to high purity. This product can be fluorinated and methylated, which allows for the attachment of glycosyl groups. Glycyl-monosialyllacto-N-neohexose I is also a sugar with a CAS number. It has an average molecular weight of 137.14 g/mol and is made up of three atoms: carbon, hydrogen, and oxygen.

NGA2F Glycan is a complex carbohydrate that is synthesized by the enzymatic transfer of an N-acetylgalactosamine (GalNAc) residue to a serine or threonine residue on protein. It is modified with methylation, Click modification, and fluorination. NGA2F Glycan has two binding sites for 2-AB labelled monosaccharides. The glycosylation site is located at the non-reducing end of the molecule, while the oligosaccharide site is located at the reducing end of the molecule.

Lactose is the principal sugar in human and most other mammalian milks, ( 4-O-(β-d-galactopyranosyl)-d-glucopyranose) (Collins, 2006). Lactose undergoes mutarotation; it is a reducing sugar and is significantly less soluble in water than sucrose. Lactose is much less sweet than sucrose (at ~1% about 0.15 (sucrose=1). The enzyme lactase (β-galactosidase), which is present in the small intestine, catalyzes hydrolysis of lactose to form glucose and galactose. Anhydrous lactose is an excipient, filler, diluent, and bulking agent in a wide variety of pharmaceutical tablets, capsules, powders and other preparations. Lactose also has applications as a nutrient and multi-functional ingredient in infant formulae, geriatric, dietetic and health foods (Linko, 1982).

2'-O-Fucosyllactulose is a modified carbohydrate that has been synthesized from a natural source. It is an oligosaccharide that contains the monosaccharide, fucose. This product can be used in the synthesis of polysaccharides and glycosylation reactions. 2'-O-Fucosyllactulose has been methylated, fluorinated, and glycosylated, which makes it suitable for use as a sugar in biotechnology applications.

Hybrid Glycan, 2-AB labelled is a custom synthesis of a high purity glycosylation product. This synthetic oligosaccharide includes saccharides that are labelled with 2-AB. The modification is Click chemistry and provides a method for attaching the label to the sugar molecule. This product is not found in nature or existing in cells or organisms. It is used as a research tool in immunology, cell biology, and structural biology applications.